Med. praxi. 2010;7(3):135-138

Acute and recurrent acute urinary tract infections

doc.MUDr.Miroslava Horáčková, CSc.
Interní klinika –, oddělení klinické nefrologie a hemodialýzy 2. LF UK a FN Motol, Praha

The epidemiology, etiology, etiopathogenesis, clinical presentation, treatment and prophylaxis of acute and recurrent acute urinary tract

infections are analyzed. To provide a clinical perspective of this issue, the most convenient division into uncomplicated and complicated

forms is used, with an emphasis placed on the differences in the therapeutic approach to both acute and recurrent acute urinary tract

infections.

Keywords: acute urinary tract infections, recurrent urinary tract infections, pathogenesis, treatment, prophylaxis

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáčková M. Acute and recurrent acute urinary tract infections. Med. praxi. 2010;7(3):135-138.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Foxman B. Reccuring urinary tract infection. Am J Public Health, 1990; 80: 331-333. Go to original source... Go to PubMed...
    2. Stapleton A. Host factors in susceptibility to urinary tract infections. Adv Exp Med Biol, 1999; 462: 351-358. Go to original source... Go to PubMed...
    3. Stapleton AE, Stroud MR, Hahomori SI, Stamm WE. The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissue and is a preffered binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins. Infect Immun, 1998; 66: 3856-3861. Go to original source... Go to PubMed...
    4. Williams A, Schaeffer AJ. Current concepts in urinary tract infectuions. Minerva Urol Neophrol, 2004; 561: 15-31.
    5. Bartoníčková K, Bébrová E, Beneš J, Čížek J, Dostál V, Galský J, Horáčková M, Chmelík V, Jindrák V, Karen I, Kolář M, Kolská M, Kolský A, Marek J, Marešová V, Matoušková M, Nýč O, Urbášková P. Doporučený postup pro antibiotickou léčbu komunitních infekcí ledvin a močových cest v primární péči. Prakt Lék, 2006; 86(8): 429-438.
    6. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heusen J, Hultergren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science, 2003; 301: 105-107. Go to original source... Go to PubMed...
    7. Patton JP, Nash DB, Abrutyn E. Urinary tract infections. Economic considerations. Med Clin North Am, 1991; 75: 495-513. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.